Editorial
Published on 20 Jul 2023
Editorial: Anti-cancer drug delivery: lipid-based nanoparticles
in Pharmacology of Anti-Cancer Drugs
Frontiers in Oncology
doi 10.3389/fonc.2023.1248272
- 2,381 views
- 1 citation
Type at least 3 characters
1,074 articles
Original Research
Published on 18 Jul 2023
Effect of four fluoroquinolones on the viability of bladder cancer cells in 2D and 3D cultures
in Pharmacology of Anti-Cancer Drugs
Frontiers in Oncology
doi 10.3389/fonc.2023.1222411
- 3,289 views
- 7 citations
Review
Published on 14 Jul 2023
A literature review on the impact of disasters on healthcare systems, the role of nursing in disaster management, and strategies for cancer care delivery in disaster-affected populations
in Pharmacology of Anti-Cancer Drugs
Frontiers in Oncology
doi 10.3389/fonc.2023.1178092
- 8,899 views
- 7 citations
Original Research
Published on 11 Jul 2023
PIWIL1 interacting RNA piR-017724 inhibits proliferation, invasion, and migration, and inhibits the development of HCC by silencing PLIN3
in Pharmacology of Anti-Cancer Drugs
Frontiers in Oncology
doi 10.3389/fonc.2023.1203821
- 2,540 views
- 11 citations
Review
Published on 10 Jul 2023
Hypoxia: syndicating triple negative breast cancer against various therapeutic regimens
in Pharmacology of Anti-Cancer Drugs
Frontiers in Oncology
doi 10.3389/fonc.2023.1199105
- 10,720 views
- 29 citations
Review
Published on 06 Jul 2023
Insight into lipid-based nanoplatform-mediated drug and gene delivery in neuro-oncology and their clinical prospects
in Pharmacology of Anti-Cancer Drugs
Frontiers in Oncology
doi 10.3389/fonc.2023.1168454
- 3,981 views
- 5 citations
Review
Published on 04 Jul 2023
Malignant mesothelioma tumours: molecular pathogenesis, diagnosis, and therapies accompanying clinical studies
in Pharmacology of Anti-Cancer Drugs
Frontiers in Oncology
doi 10.3389/fonc.2023.1204722
- 11,609 views
- 20 citations
Case Report
Published on 03 Jul 2023
Intravenous immunoglobulin is safe and effective in controlling pre-existing paraneoplastic neuromuscular diseases in cancer patients treated with immune checkpoint inhibitors: two case reports and literature review
in Pharmacology of Anti-Cancer Drugs
Frontiers in Oncology
doi 10.3389/fonc.2023.1199195
- 4,642 views
- 3 citations
Case Report
Published on 30 Jun 2023
Case Report: Advanced pulmonary sarcomatoid carcinoma with adrenal gland metastasis after sintilimab combined with anlotinib treatment
in Pharmacology of Anti-Cancer Drugs
Frontiers in Oncology
doi 10.3389/fonc.2023.1167516
- 2,926 views
- 7 citations
Editorial
Published on 26 Jun 2023
Editorial: Novel targeted drugs for indolent lymphoid malignancies
in Pharmacology of Anti-Cancer Drugs
Frontiers in Oncology
doi 10.3389/fonc.2023.1224528
- 1,788 views
Original Research
Published on 20 Jun 2023
Adjuvant composite cold atmospheric plasma therapy increases antitumoral effect of doxorubicin hydrochloride
in Pharmacology of Anti-Cancer Drugs
Frontiers in Oncology
doi 10.3389/fonc.2023.1171042
- 3,173 views
- 6 citations
Editorial
Published on 20 Jun 2023
Editorial: Epithelial-mesenchymal transition (EMT) as a therapeutic target in cancer, Volume II
in Pharmacology of Anti-Cancer Drugs
Frontiers in Oncology
doi 10.3389/fonc.2023.1218855
- 2,161 views
- 3 citations
Editorial
Published on 19 Jun 2023
Editorial: RNA recognition landscapes and anticancer drug targeting
in Pharmacology of Anti-Cancer Drugs
Frontiers in Oncology
doi 10.3389/fonc.2023.1222883
- 1,220 views
Review
Published on 19 Jun 2023
Functional role of MicroRNA/PI3K/AKT axis in osteosarcoma
in Pharmacology of Anti-Cancer Drugs
Frontiers in Oncology
doi 10.3389/fonc.2023.1219211
- 6,380 views
- 11 citations
Review
Published on 16 Jun 2023
Anticancer properties of sulforaphane: current insights at the molecular level
in Pharmacology of Anti-Cancer Drugs
Frontiers in Oncology
doi 10.3389/fonc.2023.1168321
- 29,456 views
- 35 citations
Original Research
Published on 15 Jun 2023
Evaluating the iron chelator function of sirtinol in non-small cell lung cancer
in Pharmacology of Anti-Cancer Drugs
Frontiers in Oncology
doi 10.3389/fonc.2023.1185715
- 2,568 views
- 7 citations